2025 Speakers

Michele M. Oshman is Senior Vice President of External Affairs and Head of BIO’s Patient Advocacy. BIO is the world’s largest trade association representing biotechnology companies. In her role, Ms. Oshman leads BIO’s engagement with patient advocacy and other key stakeholder communities, drives support for members’ patient advocacy and external engagement needs, and ensures BIO’s policies reflect patient perspectives. Ms. Oshman joined BIO in January 2020 after 18 years at Eli Lilly and Company, where she led federal alliance development outreach. She began her career as a clinical neuroscience researcher and held various leadership roles in clinical development and corporate strategy. In 2005, she earned a Six Sigma Black Belt and led transformational initiatives before joining the advocacy team in 2007. From 2012-2015, she served as Chair of the Biotechnology Innovation Organization (BIO) Alliance Committee and chaired the PhRMA Alliance Development Section in 2016. She also chaired the Arthritis Foundation Industry Forum from 2014-2016 and co-chairs the Lupus Foundation of America corporate council. Ms. Oshman serves on the Board of Directors for the National Health Council (NHC), consisting of over 160 health-related organizations. She is in her second term on the Board of the American Brain Coalition and recently completed her tenure on the Capital Clubhouse Board. In 2023, she was elected to Health On Wednesday, a women’s organization for executive health policy leaders. Ms. Oshman also serves on the Committee on Nominations and Leadership Development for the American Association for the Advancement of Science (AAAS). An active member of the Japan America Society of Washington DC, Ms. Oshman graduated from American University with degrees in Political Science and Communications. She also pursued a Doctor of Pharmacy at the University of Maryland, Baltimore. She has two children, a husband of over 25 years, and an oversized dog.